The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation.
Aikaterini Gatsiou, Simon Tual-Chalot, Matteo Napoli...
https://pubmed.ncbi.nlm.nih.gov/37100060Actively Recruiting
Led by University of Utah · Updated on 2025-07-15
300
Participants Needed
3
Research Sites
N/A
Total Duration
U
University of Utah
Lead Sponsor
I
Intermountain Health Care, Inc.
Collaborating Sponsor
Researchers are investigating changes in heart tissue and blood in patients with advanced heart disease, focusing on those with end-stage heart failure undergoing left ventricular assist device (LVAD) implantation or heart transplantation. The study aims to collect tissue and serum samples to better understand the basic science of heart disease. Samples from healthy donor hearts not used for transplantation will serve as comparison controls. This observational registry project does not involve any investigational drugs or procedures and focuses on gathering functional, structural, and molecular data related to heart failure. Participants in the advanced heart failure group will have tissue samples collected during their LVAD implantation surgery from the portion of the left ventricular apex removed as part of the procedure. Blood samples will be drawn at specific times during the study, either during scheduled procedures or alongside other lab work. Control samples will be obtained from patients undergoing other cardiac surgeries where tissue is routinely discarded. No additional tissue beyond standard surgical removal will be collected. During the study, participants will provide consent and have blood samples taken at defined time points. Researchers will monitor changes in myocardial function from baseline to three months after procedures. The project stores and organizes collected data and tissue samples for future research but does not affect current treatment plans. The study involves ongoing monitoring and data collection, with overall participation duration varying based on individual procedures and follow-up schedules.
CONDITIONS
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Blood and tissue samples are collected during cardiac surgery procedures as part of routine care.
1 visit (in-person)
Duration - 3 months
Participants are observed for changes in myocardial function over time after surgery.
1 follow-up visit
Total: 3 locations
1
Intermountain Medical Center
Murray, Utah, United States, 84157
Actively Recruiting
2
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132
Actively Recruiting
3
VA Salt Lake City Health Care System
Salt Lake City, Utah, United States, 84148
Actively Recruiting
J
John Kirk
S
Stavros Drakos, M.D., Ph.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Aikaterini Gatsiou, Simon Tual-Chalot, Matteo Napoli...
https://pubmed.ncbi.nlm.nih.gov/37100060